Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
161 hedge funds and large institutions have $695M invested in Meridian Bioscience Inc in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 58 reducing their positions, and 16 closing their positions.
0% more funds holding
Funds holding: 161 → 161 (0)
0% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 16
7% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 58
15% less capital invested
Capital invested by funds: $815M → $695M (-$120M)
78% less call options, than puts
Call options by funds: $522K | Put options by funds: $2.32M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$63.6M |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
+$3.82M |
| 3 |
Millennium Management
New York
|
+$3.77M |
| 4 |
RA
Royce & Associates
New York
|
+$3.5M |
| 5 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
+$2.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$25M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$15.2M |
| 3 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
-$13.8M |
| 4 |
BA
Broadview Advisors
Milwaukee,
Wisconsin
|
-$13.1M |
| 5 |
Neuberger Berman Group
New York
|
-$11.1M |
VIVO Hedge Fund Activity: Q3 2014 in Review
161 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2014, worth a combined $695M — down 15% from $815M a quarter earlier.
Fund positioning in VIVO was balanced in Q3 2014: 16 funds opened new positions, 16 closed out, 54 added to existing stakes and 58 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $63.6M. The largest seller was Boston Trust Walden, exiting entirely with an estimated $25M sold.
- 161 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $695M of Meridian Bioscience Inc stock for Q3 2014, down 15% quarter-over-quarter.
- 16 funds opened new Meridian Bioscience Inc positions in Q3 2014 and 16 closed out, a net change of 0 holders.
- The largest Meridian Bioscience Inc buyer in Q3 2014 was Fidelity Investments, an estimated $63.6M added.
- The largest Meridian Bioscience Inc seller in Q3 2014 was Boston Trust Walden, an estimated $25M sold.
Based on aggregated 13F filings for Q3 2014.